MetaADEDB 2.0 @ LMMD
palbociclib
(AHJRHEGDXFFMBM-UHFFFAOYSA-N)
Structure
SMILES
CC(=O)c1c(C)c2cnc(nc2n(c1=O)C1CCCC1)Nc1ccc(cn1)N1CCNCC1
Type(s)
Approved; Investigational
ATC code(s)
L01XE33
Molecular Formula:
C24H29N7O2
Molecular Weight:
447.533
Log P:
3.4326
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
105.04
CAS Number(s):
571190-30-2
Synonym(s)
1.
palbociclib
2.
6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one
3.
Ibrance
4.
PD 0332991
5.
PD-0332991
6.
PD0332991
External Link(s)
MeSHC500026
PubChem Compound5330286
BindingDB6309
ChEBI85993
CHEMBLCHEMBL189963
DrugBankDB09073
DrugCentral4941
IUPHAR/BPS Guide to PHARMACOLOGY7380
KEGGdr:D10372
Therapeutic Target DatabaseD00UZR
D07QXO
ZINC3938686
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 3374
Canada Vigilance: 5
21610706
22090362
25524798
CTD
Canada Vigilance
US FAERS
2White blood cell count decreasedFAERS: 2495
Canada Vigilance: 7
Canada Vigilance
US FAERS
3NauseaFAERS: 1806
Canada Vigilance: 5
21610706
22090362
CTD
Canada Vigilance
US FAERS
4AlopeciaFAERS: 1359
Canada Vigilance: 2
Canada Vigilance
US FAERS
5NeutropeniaFAERS: 1156
Canada Vigilance: 68

View details

CTD
Canada Vigilance
US FAERS
6AstheniaFAERS: 635
Canada Vigilance: 2
Canada Vigilance
US FAERS
7StomatitisFAERS: 634
Canada Vigilance: 3
Canada Vigilance
US FAERS
8VomitingFAERS: 629
Canada Vigilance: 4
19164198
21610706
CTD
Canada Vigilance
US FAERS
9MalaiseFAERS: 622
Canada Vigilance: 2
Canada Vigilance
US FAERS
10Disease ProgressionFAERS: 578US FAERS
11Full blood count decreasedFAERS: 578
Canada Vigilance: 3
Canada Vigilance
US FAERS
12ConstipationFAERS: 550
Canada Vigilance: 1
21610706CTD
Canada Vigilance
US FAERS
13HeadacheFAERS: 548
Canada Vigilance: 1
19164198
21610706
CTD
Canada Vigilance
US FAERS
14DizzinessFAERS: 512
Canada Vigilance: 1
Canada Vigilance
US FAERS
15PainFAERS: 496
Canada Vigilance: 2
Canada Vigilance
US FAERS
16ArthralgiaFAERS: 485
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Drug dose omissionFAERS: 395US FAERS
18EpistaxisFAERS: 37721610706CTD
US FAERS
19PruritusFAERS: 342US FAERS
20Weight decreasedFAERS: 333
Canada Vigilance: 1
Canada Vigilance
US FAERS
21NasopharyngitisFAERS: 330US FAERS
22Back PainFAERS: 320
Canada Vigilance: 1
25524798CTD
Canada Vigilance
US FAERS
23Product use issueFAERS: 319
Canada Vigilance: 1
Canada Vigilance
US FAERS
24Neutrophil count decreasedFAERS: 299
Canada Vigilance: 11
Canada Vigilance
US FAERS
25Bone painFAERS: 279
Canada Vigilance: 1
Canada Vigilance
US FAERS
26PneumoniaFAERS: 265
Canada Vigilance: 6
Canada Vigilance
US FAERS
27Abdominal discomfortFAERS: 258US FAERS
28LeukopeniaFAERS: 25721610706
22090362
25524798
CTD
US FAERS
29Dry skinFAERS: 256US FAERS
30Peripheral swellingFAERS: 254
Canada Vigilance: 1
Canada Vigilance
US FAERS
31Product use in unapproved indicationFAERS: 239
Canada Vigilance: 6
Canada Vigilance
US FAERS
32Blood count abnormalFAERS: 229
Canada Vigilance: 3
Canada Vigilance
US FAERS
33Memory impairmentFAERS: 216US FAERS
34DysgeusiaFAERS: 207US FAERS
35DehydrationFAERS: 196US FAERS
36Urinary tract infectionFAERS: 195US FAERS
37ThrombocytopeniaFAERS: 192
Canada Vigilance: 6
21610706
23569312
25501126
CTD
Canada Vigilance
US FAERS
38Oropharyngeal painFAERS: 190
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Oral painFAERS: 186US FAERS
40MyalgiaFAERS: 168US FAERS
41InfluenzaFAERS: 163
Canada Vigilance: 2
Canada Vigilance
US FAERS
42DyspepsiaFAERS: 162US FAERS
43Feeling abnormalFAERS: 159US FAERS
44Therapy cessationFAERS: 159
Canada Vigilance: 1
Canada Vigilance
US FAERS
45SomnolenceFAERS: 151US FAERS
46ChillsFAERS: 150US FAERS
47Abdominal PainFAERS: 148US FAERS
48Drug ineffectiveFAERS: 144
Canada Vigilance: 2
Canada Vigilance
US FAERS
49Product dose omissionFAERS: 140US FAERS
50InfectionFAERS: 131
Canada Vigilance: 2
Canada Vigilance
US FAERS
51ThrombosisFAERS: 124US FAERS
52AnxietyFAERS: 105US FAERS
53Chest PainFAERS: 105US FAERS
54PancytopeniaFAERS: 102
Canada Vigilance: 1
Canada Vigilance
US FAERS
55SinusitisFAERS: 102US FAERS
56HypersensitivityFAERS: 90US FAERS
57Musculoskeletal PainFAERS: 88US FAERS
58Productive CoughFAERS: 83US FAERS
59Joint swellingFAERS: 81US FAERS
60DysphoniaFAERS: 80US FAERS
61Febrile NeutropeniaFAERS: 78
Canada Vigilance: 7
Canada Vigilance
US FAERS
62Pulmonary EmbolismFAERS: 78
Canada Vigilance: 6
25524798CTD
Canada Vigilance
US FAERS
63BronchitisFAERS: 75
Canada Vigilance: 2
Canada Vigilance
US FAERS
64HypotensionFAERS: 75US FAERS
65Blood glucose increasedFAERS: 74US FAERS
66Intentional product misuseFAERS: 74US FAERS
67Cerebrovascular accidentFAERS: 73
Canada Vigilance: 2
Canada Vigilance
US FAERS
68Night sweatsFAERS: 72US FAERS
69Therapy changeFAERS: 70US FAERS
70ErythemaFAERS: 68
Canada Vigilance: 1
Canada Vigilance
US FAERS
71FlatulenceFAERS: 68US FAERS
72Visual ImpairmentFAERS: 67US FAERS
73TremorFAERS: 65US FAERS
74CytopeniaFAERS: 63
Canada Vigilance: 3
Canada Vigilance
US FAERS
75Burning sensationFAERS: 62US FAERS
76SepsisFAERS: 62US FAERS
77Blood potassium decreasedFAERS: 59
Canada Vigilance: 1
Canada Vigilance
US FAERS
78Musculoskeletal stiffnessFAERS: 58US FAERS
79AmnesiaFAERS: 57US FAERS
80White blood cell count abnormalFAERS: 57US FAERS
81Decreased immune responsivenessFAERS: 56US FAERS
82Blood creatinine increasedFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Neck PainFAERS: 53US FAERS
84AscitesFAERS: 52US FAERS
85Musculoskeletal chest painFAERS: 52US FAERS
86OnychoclasisFAERS: 51US FAERS
87SwellingFAERS: 51US FAERS
88CellulitisFAERS: 50US FAERS
89StressFAERS: 50US FAERS
90HypersomniaFAERS: 49US FAERS
91UrticariaFAERS: 49US FAERS
92AgeusiaFAERS: 47US FAERS
93ArthritisFAERS: 45US FAERS
94CataractFAERS: 44US FAERS
95NervousnessFAERS: 42US FAERS
96Chest discomfortFAERS: 40US FAERS
97Depressed moodFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Diabetes MellitusFAERS: 40US FAERS
99VertigoFAERS: 40US FAERS
100DeafnessFAERS: 39US FAERS
101Emotional disorderFAERS: 39US FAERS
102Feeling ColdFAERS: 39US FAERS
103CystitisFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
104Throat irritationFAERS: 38US FAERS
105LethargyFAERS: 37US FAERS
106Gait inabilityFAERS: 36US FAERS
107Myocardial InfarctionFAERS: 36US FAERS
108DysuriaFAERS: 35US FAERS
109Therapeutic response unexpectedFAERS: 35US FAERS
110Full blood count abnormalFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
111Skin lesionFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
112SyncopeFAERS: 33US FAERS
113CryingFAERS: 32US FAERS
114Limb discomfortFAERS: 32US FAERS
115NeuralgiaFAERS: 31US FAERS
116ToothacheFAERS: 31US FAERS
117Viral upper respiratory tract infectionFAERS: 31US FAERS
118Pulmonary thrombosisFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
119AcneFAERS: 29US FAERS
120Blood glucose decreasedFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
121Deep Vein ThrombosisFAERS: 29US FAERS
122PalpitationsFAERS: 29US FAERS
123Rash erythematousFAERS: 29US FAERS
124SneezingFAERS: 28US FAERS
125Atrial FibrillationFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
126Poor quality sleepFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
127RetchingFAERS: 26US FAERS
128Therapy non-responderFAERS: 26US FAERS
129Wrong technique in product usage processFAERS: 26US FAERS
130DementiaFAERS: 25US FAERS
131General physical health deteriorationFAERS: 25US FAERS
132Loss of personal independence in daily activitiesFAERS: 25US FAERS
133Blood iron decreasedFAERS: 24US FAERS
134Mental impairmentFAERS: 24US FAERS
135Nasal discomfortFAERS: 24US FAERS
136SciaticaFAERS: 24US FAERS
137Urinary IncontinenceFAERS: 24US FAERS
138BlindnessFAERS: 23US FAERS
139Malignant neoplasm progressionFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
140No adverse eventFAERS: 23US FAERS
141PneumonitisFAERS: 23US FAERS
142AphoniaFAERS: 22US FAERS
143Joint stiffnessFAERS: 22US FAERS
144Pain of skinFAERS: 22US FAERS
145WheezingFAERS: 22US FAERS
146Aspartate Aminotransferase IncreasedFAERS: 21US FAERS
147DiverticulitisFAERS: 21US FAERS
148Pre-existing condition improvedFAERS: 21US FAERS
149TinnitusFAERS: 21US FAERS
150Alanine Aminotransferase IncreasedFAERS: 20US FAERS
151EructationFAERS: 19US FAERS
152Eye painFAERS: 19US FAERS
153NephrolithiasisFAERS: 19US FAERS
154AgitationFAERS: 18US FAERS
155AsthmaFAERS: 18US FAERS
156Blood potassium increasedFAERS: 18US FAERS
157Blood urine presentFAERS: 18US FAERS
158HepatotoxicityFAERS: 18US FAERS
159LaryngitisFAERS: 18US FAERS
160Limb injuryFAERS: 18US FAERS
161OsteoporosisFAERS: 18US FAERS
162ColitisFAERS: 17US FAERS
163Increased tendency to bruiseFAERS: 17US FAERS
164InflammationFAERS: 17US FAERS
165Lower respiratory tract infectionFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
166Acute kidney injuryFAERS: 16US FAERS
167Eye irritationFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
168FlushingFAERS: 16US FAERS
169GastritisFAERS: 16US FAERS
170Middle insomniaFAERS: 16US FAERS
171Paranasal sinus hypersecretionFAERS: 16US FAERS
172Product storage errorFAERS: 16US FAERS
173Tooth InfectionFAERS: 16US FAERS
174Unevaluable eventFAERS: 16US FAERS
175Blood sodium decreasedFAERS: 15US FAERS
176Clostridium difficile infectionFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
177DiplopiaFAERS: 15US FAERS
178HungerFAERS: 15US FAERS
179Lip swellingFAERS: 15US FAERS
180Mood swingsFAERS: 15US FAERS
181Paranasal sinus discomfortFAERS: 15US FAERS
182Psychiatric symptomFAERS: 15US FAERS
183ThirstFAERS: 15US FAERS
184CheilitisFAERS: 14US FAERS
185Disease recurrenceFAERS: 14US FAERS
186Inappropriate schedule of drug administrationFAERS: 14US FAERS
187LymphadenopathyFAERS: 14US FAERS
188Osteonecrosis of JawFAERS: 14US FAERS
189Pericardial effusionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
190Skin irritationFAERS: 14US FAERS
191ChromaturiaFAERS: 13US FAERS
192Device related infectionFAERS: 13US FAERS
193Incorrect dose administeredFAERS: 13US FAERS
194Poor quality drug administeredFAERS: 13US FAERS
195Pulmonary congestionFAERS: 13US FAERS
196UlcerFAERS: 13US FAERS
197AngerFAERS: 12US FAERS
198Ear discomfortFAERS: 12US FAERS
199FractureFAERS: 12US FAERS
200HaematotoxicityFAERS: 12US FAERS
201HypophagiaFAERS: 12US FAERS
202Joint injuryFAERS: 12US FAERS
203Musculoskeletal discomfortFAERS: 12US FAERS
204ScabFAERS: 12US FAERS
205Skin UlcerFAERS: 12US FAERS
206Tooth LossFAERS: 12US FAERS
207Upper-airway cough syndromeFAERS: 12US FAERS
208Cardiac ArrestFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
209DisorientationFAERS: 11US FAERS
210Drug dispensing errorFAERS: 11US FAERS
211Extra dose administeredFAERS: 11US FAERS
212GingivitisFAERS: 11US FAERS
213HyperchlorhydriaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
214HypokinesiaFAERS: 11US FAERS
215Intestinal ObstructionFAERS: 11US FAERS
216Respiratory tract congestionFAERS: 11US FAERS
217Skin reactionFAERS: 11US FAERS
218Tongue blisteringFAERS: 11US FAERS
219Accidental overdoseFAERS: 10US FAERS
220ArthropathyFAERS: 10US FAERS
221Carpal Tunnel SyndromeFAERS: 10US FAERS
222DermatitisFAERS: 10US FAERS
223DiscomfortFAERS: 10US FAERS
224Drug administration errorFAERS: 10US FAERS
225EczemaFAERS: 10US FAERS
226Feeling of body temperature changeFAERS: 10US FAERS
227Flank PainFAERS: 10US FAERS
228Gastric ulcerFAERS: 10US FAERS
229Head discomfortFAERS: 10US FAERS
230OsteomyelitisFAERS: 10US FAERS
231Product dispensing errorFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
232Product size issueFAERS: 10US FAERS
233Product use complaintFAERS: 10US FAERS
234PsoriasisFAERS: 10US FAERS
235Pulmonary FibrosisFAERS: 10US FAERS
236Restless Legs SyndromeFAERS: 10US FAERS
237Vitreous floatersFAERS: 10US FAERS
238Wound InfectionFAERS: 10US FAERS
239treatment failureFAERS: 10US FAERS
240AphasiaFAERS: 9US FAERS
241Back disorderFAERS: 9US FAERS
242Cancer PainFAERS: 9US FAERS
243CholelithiasisFAERS: 9US FAERS
244CystFAERS: 9US FAERS
245Eye InfectionFAERS: 9US FAERS
246Full blood count increasedFAERS: 9US FAERS
247Granulocyte count decreasedFAERS: 9US FAERS
248HypogeusiaFAERS: 9US FAERS
249IncontinenceFAERS: 9US FAERS
250MacrocytosisFAERS: 9US FAERS
251Mouth swellingFAERS: 9US FAERS
252Pelvic PainFAERS: 9US FAERS
253Sinus headacheFAERS: 9US FAERS
254TachycardiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
255Temperature intoleranceFAERS: 9US FAERS
256Upper respiratory tract congestionFAERS: 9US FAERS
257Activities of daily living impairedFAERS: 8US FAERS
258Blood magnesium decreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
259Bowel movement irregularityFAERS: 8US FAERS
260ChokingFAERS: 8US FAERS
261Electrolyte imbalanceFAERS: 8US FAERS
262LacerationFAERS: 8US FAERS
263Lymphocyte count increasedFAERS: 8US FAERS
264Muscle strainFAERS: 8US FAERS
265NocturiaFAERS: 8US FAERS
266Product physical issueFAERS: 8US FAERS
267Renal painFAERS: 8US FAERS
268Respiratory FailureFAERS: 8US FAERS
269Adverse eventFAERS: 7US FAERS
270Ankle FractureFAERS: 7US FAERS
271AsthenopiaFAERS: 7US FAERS
272BedriddenFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
273Cerebral disorderFAERS: 7US FAERS
274DiverticulumFAERS: 7US FAERS
275Expired product administeredFAERS: 7US FAERS
276Facial paralysisFAERS: 7US FAERS
277Food cravingFAERS: 7US FAERS
278Frustration tolerance decreasedFAERS: 7US FAERS
279GlaucomaFAERS: 7US FAERS
280HepatitisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
281HerniaFAERS: 7US FAERS
282HordeolumFAERS: 7US FAERS
283ImmunosuppressionFAERS: 7US FAERS
284Impaired driving abilityFAERS: 7US FAERS
285Intentional dose omissionFAERS: 7US FAERS
286Lymphocyte count decreasedFAERS: 7US FAERS
287NoduleFAERS: 7US FAERS
288Oral candidiasisFAERS: 7US FAERS
289PancreatitisFAERS: 7US FAERS
290Pathological fractureFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
291RestlessnessFAERS: 7US FAERS
292Vulvovaginal drynessFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
293AbasiaFAERS: 6US FAERS
294Abdominal tendernessFAERS: 6US FAERS
295Allergic sinusitisFAERS: 6US FAERS
296AnosmiaFAERS: 6US FAERS
297Arthropod biteFAERS: 6US FAERS
298Blood cholesterol increasedFAERS: 6US FAERS
299Blood creatinine decreasedFAERS: 6US FAERS
300Blood glucose fluctuationFAERS: 6US FAERS
301Blood pressure fluctuationFAERS: 6US FAERS
302Blood urea increasedFAERS: 6US FAERS
303Bone lesionFAERS: 6US FAERS
304CachexiaFAERS: 6US FAERS
305Carbohydrate antigen 15-3 increasedFAERS: 6US FAERS
306Drug prescribing errorFAERS: 6US FAERS
307Early satietyFAERS: 6US FAERS
308Facial PainFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
309Feeling jitteryFAERS: 6US FAERS
310Gastric infectionFAERS: 6US FAERS
311HydronephrosisFAERS: 6US FAERS
312Inappropriate schedule of product administrationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
313Lip exfoliationFAERS: 6US FAERS
314Neutrophil count abnormalFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
315PleurisyFAERS: 6US FAERS
316Radiation injuryFAERS: 6US FAERS
317Respiratory distressFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
318Secretion dischargeFAERS: 6US FAERS
319Toxicity to various agentsFAERS: 6US FAERS
320Transaminases increasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
321TrichorrhexisFAERS: 6US FAERS
322Urinary RetentionFAERS: 6US FAERS
323Vaginal DischargeFAERS: 6US FAERS
324Vulvovaginal pruritusFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
325jaundiceFAERS: 6US FAERS
326nervous system disorderFAERS: 6US FAERS
327Blood alkaline phosphatase increasedFAERS: 5US FAERS
328BradyphreniaFAERS: 5US FAERS
329Dental cariesFAERS: 5US FAERS
330DiaphragmalgiaFAERS: 5US FAERS
331Economic problemFAERS: 5US FAERS
332FibromyalgiaFAERS: 5US FAERS
333Food PoisoningFAERS: 5US FAERS
334Foreign body in respiratory tractFAERS: 5US FAERS
335GoutFAERS: 5US FAERS
336Injection site painFAERS: 5US FAERS
337Insurance issueFAERS: 5US FAERS
338Macular degenerationFAERS: 5US FAERS
339Metastatic NeoplasmFAERS: 5US FAERS
340Muscle tightnessFAERS: 5US FAERS
341Noninfective gingivitisFAERS: 5US FAERS
342OverdoseFAERS: 5US FAERS
343Platelet count abnormalFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
344Post procedural complicationFAERS: 5US FAERS
345Product quality issueFAERS: 5US FAERS
346Senile dementiaFAERS: 5US FAERS
347Septic ShockFAERS: 5US FAERS
348Skin lacerationFAERS: 5US FAERS
349Subcutaneous AbscessFAERS: 5US FAERS
350Tongue discomfortFAERS: 5US FAERS
351Acute respiratory failureFAERS: 4US FAERS
352Altered state of consciousnessFAERS: 4US FAERS
353Blood creatine increasedFAERS: 4US FAERS
354Blood phosphorus decreasedFAERS: 4US FAERS
355Bone marrow toxicityFAERS: 4US FAERS
356Carbohydrate antigen 27.29 increasedFAERS: 4US FAERS
357Cardiac FlutterFAERS: 4US FAERS
358Catheter site infectionFAERS: 4US FAERS
359Cold sweatFAERS: 4US FAERS
360ConjunctivitisFAERS: 4US FAERS
361Conversion disorderFAERS: 4US FAERS
362Dark circles under eyesFAERS: 4US FAERS
363Depressed Level of ConsciousnessFAERS: 4US FAERS
364Depression suicidalFAERS: 4US FAERS
365Dermatitis acneiformFAERS: 4US FAERS
366Ear congestionFAERS: 4US FAERS
367Echocardiogram abnormalFAERS: 4US FAERS
368Emotional distressFAERS: 4US FAERS
369EnteritisFAERS: 4US FAERS
370Febrile bone marrow aplasiaFAERS: 4US FAERS
371FormicationFAERS: 4US FAERS
372Gastrointestinal motility disorderFAERS: 4US FAERS
373Gingival blisterFAERS: 4US FAERS
374GlossitisFAERS: 4US FAERS
375Hepatitis CFAERS: 4US FAERS
376HepatomegalyFAERS: 4US FAERS
377HyperkeratosisFAERS: 4US FAERS
378HypoxiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
379IncoherentFAERS: 4US FAERS
380Initial insomniaFAERS: 4US FAERS
381Intentional product use issueFAERS: 4US FAERS
382Irritable Bowel SyndromeFAERS: 4US FAERS
383LazinessFAERS: 4US FAERS
384MYELODYSPLASTIC SYNDROMEFAERS: 4US FAERS
385Medication residue presentFAERS: 4US FAERS
386MenopauseFAERS: 4US FAERS
387MetastasisFAERS: 4US FAERS
388Multiple SclerosisFAERS: 4US FAERS
389Muscle FatigueFAERS: 4US FAERS
390Nerve injuryFAERS: 4US FAERS
391Neutropenic sepsisFAERS: 4US FAERS
392OnychalgiaFAERS: 4US FAERS
393Oral infectionFAERS: 4US FAERS
394Oropharyngeal discomfortFAERS: 4US FAERS
395PallorFAERS: 4US FAERS
396Pancreatic carcinomaFAERS: 4US FAERS
397Pelvic massFAERS: 4US FAERS
398PhotophobiaFAERS: 4US FAERS
399PneumothoraxFAERS: 4US FAERS
400Poor quality product administeredFAERS: 4US FAERS
401Product distribution issueFAERS: 4US FAERS
402Product packaging quantity issueFAERS: 4US FAERS
403Protein urine presentFAERS: 4US FAERS
404Pulmonary painFAERS: 4US FAERS
405Quality of life decreasedFAERS: 4US FAERS
406Radiation associated painFAERS: 4US FAERS
407Rheumatoid ArthritisFAERS: 4US FAERS
408RhinalgiaFAERS: 4US FAERS
409Rotator cuff syndromeFAERS: 4US FAERS
410Sensitivity to weather changeFAERS: 4US FAERS
411Spinal column injuryFAERS: 4US FAERS
412Unresponsive to stimuliFAERS: 4US FAERS
413Urine output increasedFAERS: 4US FAERS
414furuncleFAERS: 4US FAERS
415skin abrasionFAERS: 4US FAERS
416Abdominal InfectionFAERS: 3US FAERS
417Abdominal rigidityFAERS: 3US FAERS
418AbscessFAERS: 3US FAERS
419Accidental exposure to productFAERS: 3US FAERS
420Alanine aminotransferase abnormalFAERS: 3US FAERS
421AngioedemaFAERS: 3US FAERS
422AtaxiaFAERS: 3US FAERS
423AtelectasisFAERS: 3US FAERS
424Bipolar DisorderFAERS: 3US FAERS
425Bladder prolapseFAERS: 3US FAERS
426Blood blisterFAERS: 3US FAERS
427Blood creatinine abnormalFAERS: 3US FAERS
428Blood electrolytes decreasedFAERS: 3US FAERS
429Blood glucose abnormalFAERS: 3US FAERS
430Bone scan abnormalFAERS: 3US FAERS
431Breast tendernessFAERS: 3US FAERS
432Carcinoembryonic antigen increasedFAERS: 3US FAERS
433CardiomegalyFAERS: 3US FAERS
434Cataract operationFAERS: 3US FAERS
435CatarrhFAERS: 3US FAERS
436Cerebral InfarctionFAERS: 3US FAERS
437Circumstance or information capable of leading to medication errorFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
438Clostridium difficile colitisFAERS: 3US FAERS
439Creatinine renal clearance decreasedFAERS: 3US FAERS
440DeliriumFAERS: 3US FAERS
441EmbolismFAERS: 3US FAERS
442Essential TremorFAERS: 3US FAERS
443Gastrointestinal PainFAERS: 3US FAERS
444Gastrointestinal perforationFAERS: 3US FAERS
445Humidity intoleranceFAERS: 3US FAERS
446HyperthyroidismFAERS: 3US FAERS
447HypothyroidismFAERS: 3US FAERS
448IleusFAERS: 3US FAERS
449Impaired gastric emptyingFAERS: 3US FAERS
450Incorrect product storageFAERS: 3US FAERS
451Infected biteFAERS: 3US FAERS
452Limb massFAERS: 3US FAERS
453LymphomaFAERS: 3US FAERS
454LymphopeniaFAERS: 321610706CTD
US FAERS
455MaculeFAERS: 3US FAERS
456MalnutritionFAERS: 3US FAERS
457Motion SicknessFAERS: 3US FAERS
458Nasal inflammationFAERS: 3US FAERS
459ObstructionFAERS: 3US FAERS
460Ocular discomfortFAERS: 3US FAERS
461Ocular vascular disorderFAERS: 3US FAERS
462OnycholysisFAERS: 3US FAERS
463Oral contusionFAERS: 3US FAERS
464Oral mucosal eruptionFAERS: 3US FAERS
465Oropharyngeal blisteringFAERS: 3US FAERS
466Oropharyngeal plaqueFAERS: 3US FAERS
467Osteogenesis ImperfectaFAERS: 3US FAERS
468OsteopeniaFAERS: 3US FAERS
469OverweightFAERS: 3US FAERS
470ParanoiaFAERS: 3US FAERS
471Pelvic fluid collectionFAERS: 3US FAERS
472Performance status decreasedFAERS: 3US FAERS
473PharyngitisFAERS: 3US FAERS
474PresyncopeFAERS: 3US FAERS
475Product packaging issueFAERS: 3US FAERS
476Product prescribing errorFAERS: 3US FAERS
477Protein total decreasedFAERS: 3US FAERS
478PseudocirrhosisFAERS: 3US FAERS
479Pulmonary toxicityFAERS: 3US FAERS
480SchizophreniaFAERS: 3US FAERS
481Sinus painFAERS: 3US FAERS
482Skin hypertrophyFAERS: 3US FAERS
483SluggishnessFAERS: 3US FAERS
484Spinal column stenosisFAERS: 3US FAERS
485SplenomegalyFAERS: 3US FAERS
486Terminal stateFAERS: 3US FAERS
487TrismusFAERS: 3US FAERS
488Troponin increasedFAERS: 3US FAERS
489Tumour haemorrhageFAERS: 3US FAERS
490Venous ThrombosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
491Vocal Cord ParalysisFAERS: 3US FAERS
492Vulvovaginal mycotic infectionFAERS: 3US FAERS
493X-ray abnormalFAERS: 3US FAERS
494XerosisFAERS: 3US FAERS
495Adnexa uteri painFAERS: 2US FAERS
496Ammonia increasedFAERS: 2US FAERS
497Anorectal discomfortFAERS: 2US FAERS
498ApathyFAERS: 2US FAERS
499Arthropod stingFAERS: 2US FAERS
500Aspartate aminotransferase abnormalFAERS: 2US FAERS
501Biliary dilatationFAERS: 2US FAERS
502Bladder spasmFAERS: 2US FAERS
503Blood calcium abnormalFAERS: 2US FAERS
504Blood parathyroid hormone increasedFAERS: 2US FAERS
505Blood thyroid stimulating hormone abnormalFAERS: 2US FAERS
506Blood triglycerides increasedFAERS: 2US FAERS
507BradycardiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
508Breast discomfortFAERS: 2US FAERS
509BronchiectasisFAERS: 2US FAERS
510BursitisFAERS: 2US FAERS
511Cell marker increasedFAERS: 2US FAERS
512Central nervous system lesionFAERS: 2US FAERS
513Cervix carcinomaFAERS: 2US FAERS
514CholecystitisFAERS: 2US FAERS
515Completed SuicideFAERS: 2US FAERS
516Compression fractureFAERS: 2US FAERS
517Drug effect incompleteFAERS: 2US FAERS
518Drug level increasedFAERS: 2US FAERS
519Duodenal UlcerFAERS: 2US FAERS
520DysarthriaFAERS: 2US FAERS
521Ejection Fraction DecreasedFAERS: 2US FAERS
522EnuresisFAERS: 2US FAERS
523Enzyme level increasedFAERS: 2US FAERS
524Epigastric discomfortFAERS: 2US FAERS
525EpilepsyFAERS: 2US FAERS
526Escherichia infectionFAERS: 2US FAERS
527Excessive cerumen productionFAERS: 2US FAERS
528ExcoriationFAERS: 2US FAERS
529Exfoliative rashFAERS: 2US FAERS
530Eye allergyFAERS: 2US FAERS
531Eye inflammationFAERS: 2US FAERS
532Eyelid margin crustingFAERS: 2US FAERS
533Eyelid painFAERS: 2US FAERS
534FibrosisFAERS: 2US FAERS
535Fingerprint lossFAERS: 2US FAERS
536GastroenteritisFAERS: 2US FAERS
537Gastrointestinal infectionFAERS: 2US FAERS
538Gastrointestinal obstructionFAERS: 2US FAERS
539General physical condition abnormalFAERS: 2US FAERS
540Genital rashFAERS: 2US FAERS
541Grip strength decreasedFAERS: 2US FAERS
542Guillain-Barre SyndromeFAERS: 2US FAERS
543HemiparesisFAERS: 2US FAERS
544Hormone level abnormalFAERS: 2US FAERS
545Hospice CareFAERS: 2US FAERS
546HypercapniaFAERS: 2US FAERS
547HyperventilationFAERS: 2US FAERS
548HysterectomyFAERS: 2US FAERS
549Impaired work abilityFAERS: 2US FAERS
550Implant site infectionFAERS: 2US FAERS
551Inability to afford medicationFAERS: 2US FAERS
552Incision site painFAERS: 2US FAERS
553Increased upper airway secretionFAERS: 2US FAERS
554Increased viscosity of upper respiratory secretionFAERS: 2US FAERS
555Injection Site ReactionFAERS: 2US FAERS
556Intestinal PerforationFAERS: 2US FAERS
557Intracranial massFAERS: 2US FAERS
558Iron deficiencyFAERS: 2US FAERS
559Left Ventricular HypertrophyFAERS: 2US FAERS
560LeukocytosisFAERS: 2US FAERS
561Limb operationFAERS: 2US FAERS
562Lip erythemaFAERS: 2US FAERS
563Low density lipoprotein increasedFAERS: 2US FAERS
564Manufacturing product shipping issueFAERS: 2US FAERS
565MastitisFAERS: 2US FAERS
566MeningiomaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
567Migraine with AuraFAERS: 2US FAERS
568Monocyte count decreasedFAERS: 2US FAERS
569Monocyte count increasedFAERS: 2US FAERS
570MonoplegiaFAERS: 2US FAERS
571Multiple allergiesFAERS: 2US FAERS
572MutismFAERS: 2US FAERS
573Nail bed disorderFAERS: 2US FAERS
574Nipple painFAERS: 2US FAERS
575Ocular icterusFAERS: 2US FAERS
576OliguriaFAERS: 2US FAERS
577OnychomalaciaFAERS: 2US FAERS
578Oral mucosal erythemaFAERS: 2US FAERS
579Oral mucosal exfoliationFAERS: 2US FAERS
580Oral pruritusFAERS: 2US FAERS
581PanniculitisFAERS: 2US FAERS
582PetechiaeFAERS: 2US FAERS
583Pharyngeal swellingFAERS: 2US FAERS
584PhlebitisFAERS: 2US FAERS
585PoisoningFAERS: 2US FAERS
586PolyarthritisFAERS: 2US FAERS
587Poor peripheral circulationFAERS: 2US FAERS
588Positron emission tomogram abnormalFAERS: 2US FAERS
589Post procedural infectionFAERS: 2US FAERS
590Post procedural persistent drain fluidFAERS: 2US FAERS
591Premenstrual syndromeFAERS: 2US FAERS
592Procedural site reactionFAERS: 2US FAERS
593Product administration errorFAERS: 2US FAERS
594Product container seal issueFAERS: 2US FAERS
595Product label issueFAERS: 2US FAERS
596Product leakageFAERS: 2US FAERS
597Product taste abnormalFAERS: 2US FAERS
598Psychiatric decompensationFAERS: 2US FAERS
599Pulmonary HypertensionFAERS: 2US FAERS
600Purulent dischargeFAERS: 2US FAERS
601Pyloric StenosisFAERS: 2US FAERS
602Recall phenomenonFAERS: 2US FAERS
603Renal tubular necrosisFAERS: 2US FAERS
604Respiratory arrestFAERS: 2US FAERS
605Retinal DetachmentFAERS: 2US FAERS
606RhabdomyolysisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
607RhinitisFAERS: 2US FAERS
608Saliva alteredFAERS: 2US FAERS
609ShockFAERS: 2US FAERS
610Skeletal injuryFAERS: 2US FAERS
611Skin PapillomaFAERS: 2US FAERS
612Skin WrinklingFAERS: 2US FAERS
613Skin tightnessFAERS: 2US FAERS
614Sleep TalkingFAERS: 2US FAERS
615Squamous cell carcinomaFAERS: 2US FAERS
616StenosisFAERS: 2US FAERS
617Sudden deathFAERS: 2US FAERS
618Thermal burnFAERS: 2US FAERS
619ThrombophlebitisFAERS: 2US FAERS
620Vascular painFAERS: 2US FAERS
621Vitamin D abnormalFAERS: 2US FAERS
622VitiligoFAERS: 2US FAERS
623Vulvovaginal burning sensationFAERS: 2US FAERS
624Wound dehiscenceFAERS: 2US FAERS
625Wrong scheduleFAERS: 2US FAERS
626liposarcomaFAERS: 221610706
23569312
CTD
US FAERS
627Abdominal massFAERS: 1US FAERS
628Abdominal symptomFAERS: 1US FAERS
629Accidental exposure to product by childFAERS: 1US FAERS
630AcidosisFAERS: 1US FAERS
631Acute myocardial infarctionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
632Adrenal gland cancer metastaticFAERS: 1US FAERS
633AgranulocytosisFAERS: 1US FAERS
634Alcohol abuseFAERS: 1US FAERS
635Alcohol interactionFAERS: 1US FAERS
636Allergic coughFAERS: 1US FAERS
637Anal FissureFAERS: 1US FAERS
638Anaphylactic shockFAERS: 1US FAERS
639AneurysmFAERS: 1US FAERS
640Angina PectorisFAERS: 1US FAERS
641Animal scratchFAERS: 1US FAERS
642AnisocytosisFAERS: 1US FAERS
643AnuriaFAERS: 1US FAERS
644Aortic occlusionFAERS: 1US FAERS
645Aphthous StomatitisFAERS: 1US FAERS
646Apparent deathFAERS: 1US FAERS
647AppendicitisFAERS: 1US FAERS
648ArteriosclerosisFAERS: 1US FAERS
649AsphyxiaFAERS: 1US FAERS
650Atrioventricular BlockFAERS: 1US FAERS
651AuraFAERS: 1US FAERS
652Autoimmune hepatitisFAERS: 1US FAERS
653Autonomic nervous system imbalanceFAERS: 1US FAERS
654AutoscopyFAERS: 1US FAERS
655Bacterial sepsisFAERS: 1US FAERS
656Bacterial test positiveFAERS: 1US FAERS
657Benign NeoplasmFAERS: 1US FAERS
658Biliary tract infectionFAERS: 1US FAERS
659Bladder NeoplasmFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
660Blood alcohol increasedFAERS: 1US FAERS
661Blood bilirubin abnormalFAERS: 1US FAERS
662Blood fibrinogen decreasedFAERS: 1US FAERS
663Blood homocysteine increasedFAERS: 1US FAERS
664Blood iron increasedFAERS: 1US FAERS
665Blood lactate dehydrogenase increasedFAERS: 1US FAERS
666Blood phosphorus abnormalFAERS: 1US FAERS
667Blood phosphorus increasedFAERS: 1US FAERS
668Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
669Blood triglycerides decreasedFAERS: 1US FAERS
670Blood zinc decreasedFAERS: 1US FAERS
671Body surface area decreasedFAERS: 1US FAERS
672Bone decalcificationFAERS: 1US FAERS
673Bone density decreasedFAERS: 1US FAERS
674Bone fissureFAERS: 1US FAERS
675Bone marrow infiltrationFAERS: 1US FAERS
676Brain AbscessFAERS: 1US FAERS
677Breakthrough PainFAERS: 1US FAERS
678Bronchial secretion retentionFAERS: 1US FAERS
679BronchopneumopathyFAERS: 1US FAERS
680CalcinosisFAERS: 1US FAERS
681Capsular contracture associated with breast implantFAERS: 1US FAERS
682Cardiac stress test abnormalFAERS: 1US FAERS
683Carotid artery occlusionFAERS: 1US FAERS
684Catheter site painFAERS: 1US FAERS
685Cell marker decreasedFAERS: 1US FAERS
686Cerebral ThrombosisFAERS: 1US FAERS
687Cerebral cystFAERS: 1US FAERS
688Cervical cord compressionFAERS: 1US FAERS
689Chemical burn of skinFAERS: 1US FAERS
690ChemotherapyFAERS: 1US FAERS
691Cholecystitis infectiveFAERS: 1US FAERS
692ChromatopsiaFAERS: 1US FAERS
693Chronic gastritisFAERS: 1US FAERS
694ClaustrophobiaFAERS: 1US FAERS
695Clostridium test positiveFAERS: 1US FAERS
696ClumsinessFAERS: 1US FAERS
697Contrast media reactionFAERS: 1US FAERS
698Corneal InfectionFAERS: 1US FAERS
699Creatinine renal clearance increasedFAERS: 1US FAERS
700CyanosisFAERS: 1US FAERS
701Cyclic neutropeniaFAERS: 1US FAERS
702CystoceleFAERS: 1US FAERS
703Dental Restoration FailureFAERS: 1US FAERS
704Denture wearerFAERS: 1US FAERS
705Dermo-hypodermitisFAERS: 1US FAERS
706Device malfunctionFAERS: 1US FAERS
707Diabetes InsipidusFAERS: 1US FAERS
708Diabetes mellitus inadequate controlFAERS: 1US FAERS
709Diffuse alopeciaFAERS: 1US FAERS
710DiplegiaFAERS: 1US FAERS
711Disease complicationFAERS: 1US FAERS
712Disseminated Intravascular CoagulationFAERS: 1US FAERS
713DissociationFAERS: 1US FAERS
714Documented hypersensitivity to administered productFAERS: 1US FAERS
715Drug effect delayedFAERS: 1US FAERS
716Drug level below therapeuticFAERS: 1US FAERS
717Drug level decreasedFAERS: 1US FAERS
718Drug resistanceFAERS: 1US FAERS
719Drug screen positiveFAERS: 1US FAERS
720Drug specific antibody presentFAERS: 1US FAERS
721DysgraphiaFAERS: 1US FAERS
722DyslexiaFAERS: 1US FAERS
723DyspareuniaFAERS: 1US FAERS
724EcchymosisFAERS: 1US FAERS
725Electrolyte depletionFAERS: 1US FAERS
726Emergency CareFAERS: 1US FAERS
727EndocarditisFAERS: 1US FAERS
728Endodontic procedureFAERS: 1US FAERS
729Endometrial thickeningFAERS: 1US FAERS
730EndometriosisFAERS: 1US FAERS
731EnterocolitisFAERS: 1US FAERS
732EpendymomaFAERS: 1US FAERS
733ErythropeniaFAERS: 1US FAERS
734Escherichia sepsisFAERS: 1US FAERS
735Essential HypertensionFAERS: 1US FAERS
736Euphoric moodFAERS: 1US FAERS
737Exposure via skin contactFAERS: 1US FAERS
738Eyelid infectionFAERS: 1US FAERS
739Eyelid irritationFAERS: 1US FAERS
740Eyelid rashFAERS: 1US FAERS
741Eyelids pruritusFAERS: 1US FAERS
742Failure to ThriveFAERS: 1US FAERS
743Familial TremorFAERS: 1US FAERS
744Febrile infectionFAERS: 1US FAERS
745Femoral hernia incarceratedFAERS: 1US FAERS
746Fibrin D dimer increasedFAERS: 1US FAERS
747Fluid overloadFAERS: 1US FAERS
748Foaming at mouthFAERS: 1US FAERS
749FolliculitisFAERS: 1US FAERS
750Food AllergyFAERS: 1US FAERS
751Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
752Gastric DilatationFAERS: 1US FAERS
753Gastric pH increasedFAERS: 1US FAERS
754Gastrointestinal sounds abnormalFAERS: 1US FAERS
755Gastrointestinal toxicityFAERS: 1US FAERS
756Gastrointestinal ulcerFAERS: 1US FAERS
757Gene MutationFAERS: 1US FAERS
758Genital HerpesFAERS: 1US FAERS
759Genital infection fungalFAERS: 1US FAERS
760Gingival discomfortFAERS: 1US FAERS
761Gingival erythemaFAERS: 1US FAERS
762Granulocytes abnormalFAERS: 1US FAERS
763Growth retardationFAERS: 1US FAERS
764Head titubationFAERS: 1US FAERS
765Hearing disabilityFAERS: 1US FAERS
766Heavy exposure to ultraviolet lightFAERS: 1US FAERS
767HemiplegiaFAERS: 1US FAERS
768Hepatic InfectionFAERS: 1US FAERS
769Hepatic cancer metastaticFAERS: 1US FAERS
770Hepatic enzyme decreasedFAERS: 1US FAERS
771Hepatic necrosisFAERS: 1US FAERS
772HidradenitisFAERS: 1US FAERS
773Hilar lymphadenopathyFAERS: 1US FAERS
774Hip surgeryFAERS: 1US FAERS
775HirsutismFAERS: 1US FAERS
776HostilityFAERS: 1US FAERS
777Human epidermal growth factor receptor increasedFAERS: 1US FAERS
778HyperoxaluriaFAERS: 1US FAERS
779HyperpyrexiaFAERS: 1US FAERS
780Hypertensive EncephalopathyFAERS: 1US FAERS
781HypertrichosisFAERS: 1US FAERS
782HypobarismFAERS: 1US FAERS
783Impaired quality of lifeFAERS: 1US FAERS
784ImpatienceFAERS: 1US FAERS
785Infectious pleural effusionFAERS: 1US FAERS
786Infrequent bowel movementsFAERS: 1US FAERS
787Inhibitory drug interactionFAERS: 1US FAERS
788Injection site bruisingFAERS: 1US FAERS
789Intentional self-injuryFAERS: 1US FAERS
790Intercepted medication errorFAERS: 1US FAERS
791Intercostal neuralgiaFAERS: 1US FAERS
792Interferon gamma release assay positiveFAERS: 1US FAERS
793Intra-abdominal fluid collectionFAERS: 1US FAERS
794Intracranial AneurysmFAERS: 1US FAERS
795Invasive Ductal Breast CarcinomaFAERS: 1US FAERS
796IridocyclitisFAERS: 1US FAERS
797Joint Range of Motion DecreasedFAERS: 1US FAERS
798Joint destructionFAERS: 1US FAERS
799Joint warmthFAERS: 1US FAERS
800Klebsiella test positiveFAERS: 1US FAERS
801Lacrimation decreasedFAERS: 1US FAERS
802Lactose IntoleranceFAERS: 1US FAERS
803Large intestine erosionFAERS: 1US FAERS
804Large intestine perforationFAERS: 1US FAERS
805Laryngeal tremorFAERS: 1US FAERS
806LeukoencephalopathyFAERS: 1US FAERS
807Libido disorderFAERS: 1US FAERS
808Liver function test decreasedFAERS: 1US FAERS
809Loose toothFAERS: 1US FAERS
810Lung AbscessFAERS: 1US FAERS
811LymphadenitisFAERS: 1US FAERS
812Lymphatic obstructionFAERS: 1US FAERS
813Lymphocyte count abnormalFAERS: 1US FAERS
814Malignant neoplasm of spinal cordFAERS: 1US FAERS
815Malignant nipple neoplasmFAERS: 1US FAERS
816Manufacturing product storage issueFAERS: 1US FAERS
817Mastication disorderFAERS: 1US FAERS
818Megakaryocytes decreasedFAERS: 1US FAERS
819MeningitisFAERS: 1US FAERS
820Mental FatigueFAERS: 1US FAERS
821Mental status changesFAERS: 1US FAERS
822Metastases to abdominal cavityFAERS: 1US FAERS
823Metastases to stomachFAERS: 1US FAERS
824MicrocytosisFAERS: 1US FAERS
825Morning SicknessFAERS: 1US FAERS
826Mucosal InfectionFAERS: 1US FAERS
827Myocardial necrosis marker increasedFAERS: 1US FAERS
828MyopiaFAERS: 1US FAERS
829NarcolepsyFAERS: 1US FAERS
830Nasal PolypsFAERS: 1US FAERS
831NephrectomyFAERS: 1US FAERS
832NephritisFAERS: 1US FAERS
833Neutropenic colitisFAERS: 1US FAERS
834Non-cardiac chest painFAERS: 1US FAERS
835Noninfective encephalitisFAERS: 1US FAERS
836Nonspecific reactionFAERS: 1US FAERS
837Nutritional condition abnormalFAERS: 1US FAERS
838ObesityFAERS: 1US FAERS
839Obsessive-Compulsive DisorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
840Obstructive nephropathyFAERS: 1US FAERS
841Occupational exposure to productFAERS: 1US FAERS
842Oncologic complicationFAERS: 1US FAERS
843Oral fungal infectionFAERS: 1US FAERS
844Oral viral infectionFAERS: 1US FAERS
845Osteitis DeformansFAERS: 1US FAERS
846OsteosclerosisFAERS: 1US FAERS
847Ovulation disorderFAERS: 1US FAERS
848Pancreatic PseudocystFAERS: 1US FAERS
849PapuleFAERS: 1US FAERS
850ParaplegiaFAERS: 1US FAERS
851Paratracheal lymphadenopathyFAERS: 1US FAERS
852Pathologic myopiaFAERS: 1US FAERS
853Pelvic Inflammatory DiseaseFAERS: 1US FAERS
854Pelvic discomfortFAERS: 1US FAERS
855Periorbital swellingFAERS: 1US FAERS
856Peripheral arterial occlusive diseaseFAERS: 1US FAERS
857Peripheral arthritisFAERS: 1US FAERS
858Peripheral embolismFAERS: 1US FAERS
859Personality ChangeFAERS: 1US FAERS
860PertussisFAERS: 1US FAERS
861Pleuritic painFAERS: 1US FAERS
862PolyneuropathyFAERS: 1US FAERS
863PorokeratosisFAERS: 1US FAERS
864Portal HypertensionFAERS: 1US FAERS
865Post procedural dischargeFAERS: 1US FAERS
866Post procedural strokeFAERS: 1US FAERS
867Postoperative thrombosisFAERS: 1US FAERS
868Prescribed overdoseFAERS: 1US FAERS
869Product availability issueFAERS: 1US FAERS
870Product closure issueFAERS: 1US FAERS
871Product communication issueFAERS: 1US FAERS
872Product container issueFAERS: 1US FAERS
873Product counterfeitFAERS: 1US FAERS
874Product difficult to swallowFAERS: 1US FAERS
875Product dispensing issueFAERS: 1US FAERS
876Product label confusionFAERS: 1US FAERS
877Product prescribing issueFAERS: 1US FAERS
878Product solubility abnormalFAERS: 1US FAERS
879Product substitution issueFAERS: 1US FAERS
880Product used for unknown indicationFAERS: 1US FAERS
881Protein total increasedFAERS: 1US FAERS
882ProteinuriaFAERS: 1US FAERS
883Prothrombin level decreasedFAERS: 1US FAERS
884Prothrombin time abnormalFAERS: 1US FAERS
885Pulmonary InfarctionFAERS: 1US FAERS
886Pulmonary arterial hypertensionFAERS: 1US FAERS
887Pulmonary arterial pressure abnormalFAERS: 1US FAERS
888Pulmonary function test decreasedFAERS: 1US FAERS
889PurpuraFAERS: 1US FAERS
890PyomyositisFAERS: 1US FAERS
891Radiation FibrosisFAERS: 1US FAERS
892Radiation PneumonitisFAERS: 1US FAERS
893Radiation skin injuryFAERS: 1US FAERS
894Red cell distribution width abnormalFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
895Red cell distribution width decreasedFAERS: 1US FAERS
896Reflux gastritisFAERS: 1US FAERS
897RegurgitationFAERS: 1US FAERS
898Renal ColicFAERS: 1US FAERS
899Renal abscessFAERS: 1US FAERS
900Renal cystFAERS: 1US FAERS
901Respiratory fume inhalation disorderFAERS: 1US FAERS
902Respiratory tract irritationFAERS: 1US FAERS
903Retinitis PigmentosaFAERS: 1US FAERS
904RetinitisFAERS: 1US FAERS
905Retroperitoneal fibrosisFAERS: 1US FAERS
906Rheumatic FeverFAERS: 1US FAERS
907Rhinovirus infectionFAERS: 1US FAERS
908Right atrial enlargementFAERS: 1US FAERS
909RosaceaFAERS: 1US FAERS
910Salmonella test positiveFAERS: 1US FAERS
911Salpingo-oophorectomyFAERS: 1US FAERS
912SarcomaFAERS: 1US FAERS
913Secondary cerebellar degenerationFAERS: 1US FAERS
914Sensitive skinFAERS: 1US FAERS
915Severe Acute Respiratory SyndromeFAERS: 1US FAERS
916Sinus operationFAERS: 1US FAERS
917Skin necrosisFAERS: 1US FAERS
918Skin neoplasm excisionFAERS: 1US FAERS
919Slow speechFAERS: 1US FAERS
920Small intestine carcinoma metastaticFAERS: 1US FAERS
921Solar lentigoFAERS: 1US FAERS
922SomnambulismFAERS: 1US FAERS
923Stasis dermatitisFAERS: 1US FAERS
924Stevens-Johnson SyndromeFAERS: 1US FAERS
925Stomach scan abnormalFAERS: 1US FAERS
926Streptococcal urinary tract infectionFAERS: 1US FAERS
927Suicide attemptFAERS: 1US FAERS
928SunburnFAERS: 1US FAERS
929Superficial injury of eyeFAERS: 1US FAERS
930Superior Vena Cava SyndromeFAERS: 1US FAERS
931Supraventricular tachycardiaFAERS: 1US FAERS
932Suspected counterfeit productFAERS: 1US FAERS
933Suture ruptureFAERS: 1US FAERS
934Swelling of eyelidFAERS: 1US FAERS
935Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
936T-Cell LymphomaFAERS: 1US FAERS
937Teeth brittleFAERS: 1US FAERS
938Tethered Cord SyndromeFAERS: 1US FAERS
939Therapeutic product effect variableFAERS: 1US FAERS
940Thoracic vertebral fractureFAERS: 1US FAERS
941Thrombotic strokeFAERS: 1US FAERS
942ThymomaFAERS: 1US FAERS
943Thyroid hormones increasedFAERS: 1US FAERS
944Tinea PedisFAERS: 1US FAERS
945TonsillitisFAERS: 1US FAERS
946Tooth ExtractionFAERS: 1US FAERS
947Toxic Shock SyndromeFAERS: 1US FAERS
948Trigeminal NeuralgiaFAERS: 1US FAERS
949Trousseau's syndromeFAERS: 1US FAERS
950Umbilical herniaFAERS: 1US FAERS
951UnderweightFAERS: 1US FAERS
952UreterolithiasisFAERS: 1US FAERS
953Urethritis noninfectiveFAERS: 1US FAERS
954Urinary tract inflammationFAERS: 1US FAERS
955Urinary tract obstructionFAERS: 1US FAERS
956Urine flow decreasedFAERS: 1US FAERS
957Urine ketone bodyFAERS: 1US FAERS
958VIIth nerve paralysisFAERS: 1US FAERS
959Vascular device infectionFAERS: 1US FAERS
960Vascular ruptureFAERS: 1US FAERS
961Vein collapseFAERS: 1US FAERS
962Venous occlusionFAERS: 1US FAERS
963Ventricular enlargementFAERS: 1US FAERS
964Vertebral lesionFAERS: 1US FAERS
965Vital functions abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
966Vitreous DetachmentFAERS: 1US FAERS
967Vulvovaginal discomfortFAERS: 1US FAERS
968Vulvovaginal painFAERS: 1US FAERS
969Walking aid userFAERS: 1US FAERS
970Wound healing normalFAERS: 1US FAERS
971Wound infection pseudomonasFAERS: 1US FAERS
972Wrong doseFAERS: 1US FAERS
973Wrong product administeredFAERS: 1US FAERS
974YawningFAERS: 1US FAERS
975ovarian neoplasmFAERS: 1US FAERS
976Anemia

View details

CTD
977Brain Stem Neoplasms24098593CTD
978Chromosome Aberrations22751436CTD
979Diarrhea21610706
22090362
25524798
CTD
980Exanthema21610706CTD
981Hyperglycemia21610706CTD
982Hyperplasia22508966CTD
983Hyponatremia21610706CTD
984Incorrect disposal of productCanada Vigilance: 1Canada Vigilance
985KetoacidosisCanada Vigilance: 1Canada Vigilance
986Male Germ Cell Tumor19164198CTD
987Neoplasm Invasiveness22869556CTD
988Neoplasm Metastasis25501126CTD
989Neoplasms, Germ Cell and Embryonal25522918CTD
990Teratoma19164198CTD
991Testicular Neoplasms21610706CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.